The study will compare gastric bypass surgery to other medical treatment for diabetes in patients with a body mass index between 26 and 35, inclusive. Patients will receive either Roux-en-Y Gastric Bypass surgery or traditional medical therapy, and all will learn lifestyle modification techniques including diet and exercise.
Previous research has studied gastric bypass as a treatment for Type 2 Diabetes in severely obese patients — those who have a BMI over 35. These tests have been effective in improving blood glucose levels and lowering the need for medication and risk for diabetes-related death.
Read the release on the clinical trial.
Read more coverage on gastric bypass surgery:
– South Carolina to Cover 100 Obesity Surgeries Under Pilot Program
– Pittsburgh’s West Penn Bariatric Surgery Center Earns ACS Accreditation
– Study: Gastric Bypass Patients at Higher Risk for Kidney Stones After the Procedure
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.